CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
$5.93 -0.11 (-1.8212%)
Analysed CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) News Sources
Top Analyst Reports for Alphabet, Apple & Micron Technology
27-05-2026
yahoo.com
The Zacks Analyst Blog Highlights Alphabet, Apple, Micron Technology, Cumberland Pharmaceuticals and AmeriServ Financial
28-05-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS ANNOUNCES LAUNCH OF VIBATIV® IN CHINA
28-05-2026
yahoo.com
Cumberland Expands Global Reach With Vibativ Launch in China
02-06-2026
yahoo.com
Cumberland Pharmaceuticals and Vanderbilt Health Announce Potential New Therapy to Prevent Cancer Metastasis
02-06-2026
yahoo.com
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
26-06-2026
yahoo.com
Sector Update: Healthcare Stocks Gain Friday Afternoon
26-06-2026
yahoo.com
Sector Update: Healthcare Stocks Gain Late Afternoon
26-06-2026
yahoo.com
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
01-07-2026
yahoo.com
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
01-07-2026
yahoo.com
What is the current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is $5.93.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is $-0.11.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is -1.8212%.
What is the most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is .
SEC-8K** Filing Available For CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.